Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended read with SEBI Circular No. CIR/ CFD/CMD1/162/2019 dated December 24, 2019, we hereby confirm that during the quarter ended December 31, 2022, there was no deviation or variation in the utilization of proceeds of the preferential issue of Equity shares from the objects as stated in the PAS-4.
A statement of deviation or variation for the quarter ended December 31, 2022, duly reviewed by the Audit Committee of the Company is enclosed as 'Annexure'.
This disclosure will also be hosted on the Company''s website viz. www.medicointercontinental.com